Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
NCT01741142 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2012
- Completion date
- August 31, 2015
- Enrollment
- 19 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.